Non-Alcoholic Fatty Liver Disease Trial, Recruiting (NCT06495333)

Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT06495333 Sponsor: Fundacion de Investigacion Science and Education Condition: Non-Alcoholic Fatty Liver Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06495333 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Non Alcoholic Fatty Liver Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People of Hispanic ethnicity who currently live in Puerto Rico
People between 21 and 75 years old at the time of signing consent to participate
People who have evidence of a specific liver condition called MASLD, shown by a scan result (FibroScan) meeting a particular threshold (confirm with trial site for exact details)
People who are willing and able to sign a consent form and follow the study procedures

Who may not be able to join:

People who have consumed alcohol heavily for 3 or more months in the past year (generally considered more than 3 standard drinks per day for males, or more than 2 standard drinks per day for females)
People who have had a liver transplant in the past, or who are currently on a waiting list for a liver transplant
People with a history of Hepatitis B, Hepatitis C, or HIV, even if resolved
People who have taken antibiotics within 14 days before the screening appointment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Andrea Pi, BS, FDI Clinical Research

Phone: 787-722-1248

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06495333

Sponsor: Fundacion de Investigacion Science and Education

Phase: Not Applicable

Status: Recruiting

Condition: Non-Alcoholic Fatty Liver Disease

Trial contact: 787-722-1248

More information: https://clinicaltrials.gov/study/NCT06495333

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People of Hispanic ethnicity who currently live in Puerto Rico
People between 21 and 75 years old at the time of signing consent to participate
People who have evidence of a specific liver condition called MASLD, shown by a scan result (FibroScan) meeting a particular threshold (confirm with trial site for exact details)
People who are willing and able to sign a consent form and follow the study procedures

Who may not be able to join:

People who have consumed alcohol heavily for 3 or more months in the past year (generally considered more than 3 standard drinks per day for males, or more than 2 standard drinks per day for females)
People who have had a liver transplant in the past, or who are currently on a waiting list for a liver transplant
People with a history of Hepatitis B, Hepatitis C, or HIV, even if resolved
People who have taken antibiotics within 14 days before the screening appointment

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Fundacion de Investigacion Science and Education

Registry

ClinicalTrials.gov

Start date

5 July 2024

Est. completion

28 December 2024

Where this trial is recruiting

Puerto Rico

Primary endpoints

Microbiota characterization; Microbiota diversity based on eating patterns

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov